LVR-Klinikum Düsseldorf Hospital of the Heinrich-Heine University ...

Luckhaus C, Grass-Kapanke B, Blaeser I, Ihl R, Supprian T, Winterer
G, Zielasek J, Brinkmeyer J (2008): Quantitative EEG in progressing
vs stable mild cognitive impairment (MCI): results of a 1-year
follow-up study. Int J Geriatr Psychiatry 23: 1148–1155
Luckhaus C, Hennersdorf M, Bell M, Agelink MW, Zielasek J, Cordes
J (2008): Brugada syndrome as a potential cardiac risk factor
during electroconvulsive therapy (ECT). World J Biol Psychiatry 9:
150–153
Malevani J (2008): Akut agitierte psychotische Patienten – Gibt es
eine Alternative zur herkömmlichen Akuttherapie? InFo Neurologie
& Psychiatrie 10: 30–31
Malevani J (2008): Poststroke-Depression – eine häufig übersehene
Komplikation bei Schlaganfall. Klinikarzt 37: 310–314
Malevani J, Mobascher J, Cordes J, Mobascher A (2008): Differential
diagnosis of coagulation abnormalities in borderline personality
disorder. World J Biol Psychiatry 9: 78–80
Mobascher A, Brinkmeyer J, Warbrick T, Musso F, Wittsack HJ,
Stoermer R, Saleh A, Schnitzler A, Winterer G (2008): Fluctuations
in electrodermal activity reveal variations in single trial brain responses
to painful laser stimuli-a fMRI/EEG study. Neuroimage 44:
1081–1092
Mobascher A, Winterer G (2008): Mechanisms of nicotine dependence.
Pneumologie 62: 553–561
Mobascher A, Winterer G (2008): The molecular and cellular neurobiology
of nicotine abuse in schizophrenia. Pharmacopsychiatry 41,
Suppl 1: 51–59
Möller HJ, Riedel M, Jäger M, Wickelmaier F, Buchkremer G, Henn
F, Braus D, Gastpar M, Heuser I, Klosterkötter J, Maier W, Marneros
A, Rüther E, Sauer H, Hoff P, Schneider F, Schmidt LG, Ohmann
C, Gaebel W (2008): Comparison of risperidone and (low
dose) haloperidol in the treatment of first-episode schizophrenia.
Int J Neuropsychopharmacology 11: 958–967
Möller HJ, Riedel M, Jäger M, Wickelmaier F, Maier W, Kühn KU,
Buchkremer G, Heuser I, Klosterkötter J, Gastpar M, Braus DF,
Schlösser R, Schneider F, Ohmann C, Riesbeck M, Gaebel W
(2008): Short-term treatment with risperidone or haloperidol in
first-episode schizophrenia: 8-week results of a randomized controlled
trial within the German Research Network on Schizophrenia.
Int J Neuropsychopharmacol 11: 985–997
Mössner R, Schuhmacher A, Schulze-Rauschenbach S, Kühn KU,
Rujescu D, Rietschel M, Zobel A, Franke P, Wölwer W, Gaebel W,
Häfner H, Wagner M, Maier W (2008): Further evidence for a functional
role of the glutamate receptor gene GRM3 in schizophrenia.
Eur Neuropsychopharmacol 18: 768–772
Puschner B, Steffen S, Gaebel W, Freyberger H, Klein HE, Steinert T,
Muche R, Becker T (2008): Needs-oriented discharge planning and
monitoring for high utiliziers of psychiatric services (NODPAM):
Design and methods. BMC Health Serv Res 8: 152
Rolls ET, Loh M, Deco G, Winterer G (2008): Computational models of
schizophrenia and dopamine modulation in the prefrontal cortex.
Nat Rev Neurosci 9: 696–709
ReseaRch
Ruhrmann S, Paruch J, Pukrop R, Wagner M, Berning J, Schultze-
Lutter F, Janssen B, Gaebel W, Moeller HJ, Maier W, Kloster-
koetter J, Bechdolf A (2008): Reduced subjective quality of life in
persons at risk for psychosis. Acta Psychiatr Scand 117: 357–368
Seemüller F, Riedel M, Wickelmaier F, Adli M, Mundt C, Marneros A,
Laux G, Bender W, Heuser I, Zeiler J, Gaebel W, Jäger M, Möller
HJ, Henkel V (2008): Atypical symptoms in hospitalised patients
with major depressive episode: frequency, clinical characteristics,
and internal validity. Journal of Affective Disorders 108: 271–278
Supprian T (2008): Dementielle Syndrome nach Schlaganfall. Neuro-
Geriatrie 5: 103–106
Supprian T (2008): Kognitive Defizite, Depressionen, Schlafstörungen
– was gehört zur Alzheimer-Therapie? MMW 150, Sonderheft
2: 33–36
Thornicroft G, Brohan E, Rose D, Sartorius N and the INDIGO Study
Group1 (2008): Global Pattern of Anticipated and Experienced
Discrimination against People with Schizophrenia. The Lancet 373:
408–415
Ücok A, Gaebel W (2008): Side effects of atypical antipsychotics: A
brief overview. WPA Section Report. World Psychiatry 7: 58–62
Voderholzer U, Zielasek J, Gaebel W (2008): DGPPN Kongress 2007.
Die Psychiatrie als diagnostische Disziplin – Rückblick und Evaluation.
Nervenarzt 79: 372–375
Weinmann S, Hoerger S, Erath M, Kilian R, Gaebel W, Becker T
(2008): Implementation of a schizophrenia practice guideline: clinical
results. J Clin Psychiatry 69: 1299–1306
Weinmann S, Janssen B, Gaebel W, Becker T, Falkai P, Wobrock T
(2008): Sektorenübergreifende Qualitätssicherung psychiatrischer
Therapie. Die Psychiatrie 5: 266–274
Weinmann S, Janssen B, Gaebel W, Becker T, Falkai P, Wobrock T
(2008): Combining psychotherapeutic and psychopharmacological
treatment strategies (in depressive disorders) – Quality assurance
in psychiatry across all sectors. Die Psychiatrie 5: 266–274
Weinmann S, Schmid S, Erath M, Kilian R, Gaebel W, Becker T
(2008): Implementation of a schizophrenia practice guideline – clinical
results. J Clin Psychiatr 69: 1299–1306
Wessels C, Winterer G (2008): Effects of nicotine on neurodevelopment.
Nervenarzt 79: 7–8, 10–2, 14–16
Wessels C, Winterer G (2008): Brain development: nicotine-dependent
morphological and functional changes of the central nervous
system. NeuroForum 14: 199–204
Winterer G (2008): Prefrontal dopamine signaling in schizophrenia –
The Corticocentric Model. Pharmacopsychiatry 40 (Suppl 1): 45–53
Winterer G, Konrad A, Vucurevic G, Musso F, Stoeter P, Dahmen N
(2008): Association of 5‘ end neuregulin-1 (NRG1) gene variation
with subcortical medial frontal microstructure in humans. Neuroimage
40: 712–718
Wittorf A, Weber R, Herrlich J, Wiedemann G, Wölwer W, Buchkremer
G, Klingberg S (2008): Therapieakzeptanz und therapeutische Beziehung
in der frühen Phase der Verhaltenstherapie bei Negativ-
Symptomatik der Schizophrenie. Nervenheilkunde 27: 1007–1013
133